Logo image of SSA.CA

SPECTRA PRODS INC (SSA.CA) Stock Fundamental Analysis

Canada - TSX-V:SSA - CA84757D2095 - Common Stock

0.185 CAD
0 (0%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

5

Overall SSA gets a fundamental rating of 5 out of 10. We evaluated SSA against 5 industry peers in the Automobile Components industry. SSA has an excellent financial health rating, but there are some minor concerns on its profitability. SSA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SSA was profitable.
SSA had a positive operating cash flow in the past year.
SSA had positive earnings in each of the past 5 years.
In the past 5 years SSA always reported a positive cash flow from operatings.
SSA.CA Yearly Net Income VS EBIT VS OCF VS FCFSSA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K

1.2 Ratios

Looking at the Return On Assets, with a value of 4.35%, SSA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With a Return On Equity value of 5.29%, SSA perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
The Return On Invested Capital of SSA (4.69%) is worse than 80.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SSA is above the industry average of 6.27%.
Industry RankSector Rank
ROA 4.35%
ROE 5.29%
ROIC 4.69%
ROA(3y)8.04%
ROA(5y)11.02%
ROE(3y)9.81%
ROE(5y)13.13%
ROIC(3y)8.5%
ROIC(5y)12.06%
SSA.CA Yearly ROA, ROE, ROICSSA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

SSA's Profit Margin of 5.99% is amongst the best of the industry. SSA outperforms 100.00% of its industry peers.
SSA's Profit Margin has declined in the last couple of years.
The Operating Margin of SSA (7.67%) is better than 80.00% of its industry peers.
SSA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 47.41%, SSA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of SSA has declined.
Industry RankSector Rank
OM 7.67%
PM (TTM) 5.99%
GM 47.41%
OM growth 3Y-25.85%
OM growth 5Y-13.88%
PM growth 3Y-15.05%
PM growth 5Y-23.9%
GM growth 3Y-5.9%
GM growth 5Y-3.54%
SSA.CA Yearly Profit, Operating, Gross MarginsSSA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SSA is creating some value.
SSA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SSA has less shares outstanding
Compared to 1 year ago, SSA has an improved debt to assets ratio.
SSA.CA Yearly Shares OutstandingSSA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SSA.CA Yearly Total Debt VS Total AssetsSSA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

2.2 Solvency

An Altman-Z score of 3.25 indicates that SSA is not in any danger for bankruptcy at the moment.
SSA's Altman-Z score of 3.25 is amongst the best of the industry. SSA outperforms 100.00% of its industry peers.
SSA has a debt to FCF ratio of 0.57. This is a very positive value and a sign of high solvency as it would only need 0.57 years to pay back of all of its debts.
The Debt to FCF ratio of SSA (0.57) is better than 100.00% of its industry peers.
SSA has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
SSA has a better Debt to Equity ratio (0.06) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.57
Altman-Z 3.25
ROIC/WACC0.56
WACC8.35%
SSA.CA Yearly LT Debt VS Equity VS FCFSSA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K 1M -1M 1.5M

2.3 Liquidity

A Current Ratio of 7.22 indicates that SSA has no problem at all paying its short term obligations.
The Current ratio of SSA (7.22) is better than 100.00% of its industry peers.
A Quick Ratio of 6.26 indicates that SSA has no problem at all paying its short term obligations.
The Quick ratio of SSA (6.26) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 7.22
Quick Ratio 6.26
SSA.CA Yearly Current Assets VS Current LiabilitesSSA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

0

3. Growth

3.1 Past

The earnings per share for SSA have decreased strongly by -33.01% in the last year.
SSA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -27.10% yearly.
The Revenue has decreased by -5.96% in the past year.
Measured over the past years, SSA shows a decrease in Revenue. The Revenue has been decreasing by -4.04% on average per year.
EPS 1Y (TTM)-33.01%
EPS 3Y-13.54%
EPS 5Y-27.1%
EPS Q2Q%-236.36%
Revenue 1Y (TTM)-5.96%
Revenue growth 3Y-0.72%
Revenue growth 5Y-4.04%
Sales Q2Q%-10.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSA.CA Yearly Revenue VS EstimatesSSA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.50, the valuation of SSA can be described as rather expensive.
80.00% of the companies in the same industry are cheaper than SSA, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.53, SSA is valued a bit cheaper.
Industry RankSector Rank
PE 18.5
Fwd PE N/A
SSA.CA Price Earnings VS Forward Price EarningsSSA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SSA indicates a rather expensive valuation: SSA more expensive than 80.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SSA is valued a bit more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.67
EV/EBITDA 6.26
SSA.CA Per share dataSSA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

SSA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SSA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SPECTRA PRODS INC

TSX-V:SSA (10/14/2025, 7:00:00 PM)

0.185

0 (0%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners26.6%
Inst Owner ChangeN/A
Ins Owners8.25%
Ins Owner ChangeN/A
Market Cap2.52M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.5
Fwd PE N/A
P/S 1.52
P/FCF 7.67
P/OCF 7.67
P/B 1.35
P/tB 1.35
EV/EBITDA 6.26
EPS(TTM)0.01
EY5.41%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY13.04%
OCF(TTM)0.02
OCFY13.04%
SpS0.12
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.35%
ROE 5.29%
ROCE 6.38%
ROIC 4.69%
ROICexc 18.45%
ROICexgc 18.45%
OM 7.67%
PM (TTM) 5.99%
GM 47.41%
FCFM 19.87%
ROA(3y)8.04%
ROA(5y)11.02%
ROE(3y)9.81%
ROE(5y)13.13%
ROIC(3y)8.5%
ROIC(5y)12.06%
ROICexc(3y)25.04%
ROICexc(5y)32.76%
ROICexgc(3y)25.04%
ROICexgc(5y)32.76%
ROCE(3y)11.57%
ROCE(5y)16.41%
ROICexcg growth 3Y-19.46%
ROICexcg growth 5Y-7.33%
ROICexc growth 3Y-19.46%
ROICexc growth 5Y-7.33%
OM growth 3Y-25.85%
OM growth 5Y-13.88%
PM growth 3Y-15.05%
PM growth 5Y-23.9%
GM growth 3Y-5.9%
GM growth 5Y-3.54%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.57
Debt/EBITDA 0.62
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 18.97
Cash Conversion 176.75%
Profit Quality 331.75%
Current Ratio 7.22
Quick Ratio 6.26
Altman-Z 3.25
F-Score6
WACC8.35%
ROIC/WACC0.56
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)225.95%
Profit Quality(5y)198%
High Growth Momentum
Growth
EPS 1Y (TTM)-33.01%
EPS 3Y-13.54%
EPS 5Y-27.1%
EPS Q2Q%-236.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.96%
Revenue growth 3Y-0.72%
Revenue growth 5Y-4.04%
Sales Q2Q%-10.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.49%
EBIT growth 3Y-26.38%
EBIT growth 5Y-17.36%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.56%
FCF growth 3Y-7.27%
FCF growth 5Y-9.48%
OCF growth 1Y-14.56%
OCF growth 3Y-7.27%
OCF growth 5Y-9.92%